Education
About Us
Working with TipRanks
Follow Us
REPRO-MED Systems (KRMD)
NASDAQ:KRMD
KRMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.86 - $5.05
Previous CloseN/A
Volume31.78K
Average Volume (3M)152.06K
Market Cap
$191.88M
Enterprise Value$160.79M
Total Cash (Recent Filing)$8.74M
Total Debt (Recent Filing)$3.73M
Price to Earnings (P/E)―
Beta0.90
Next Earnings
Nov 05, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding46,234,960
10 Day Avg. Volume166,548
30 Day Avg. Volume152,061
Financial Highlights & Ratios
PEG Ratio0.51
Price to Book (P/B)10.49
Price to Sales (P/S)5.24
P/FCF Ratio-109.04
Enterprise Value/Market Cap0.84
Enterprise Value/Revenue4.58
Enterprise Value/Gross Profit7.22
Enterprise Value/Ebitda-34.67
Forecast
1Y Price Target
$4.75Price Target Upside14.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
Financial PerformanceKRMD delivered a strong quarter as it generated $10M in quarterly revenues for the first time and beat across the P&L, continuing to see material outperformance in its OUS markets.
Innovation And DevelopmentInnovation is alive and well with ongoing development, including multiple expected 510(K) submissions in 2025 and 2026 across its core platform and Novel Therapies.
International ExpansionGrowth of OUS has been robust as Europe transitions to prefilled syringes, a move KRMD is poised to take significant advantage of and drive share gains over its current 10-15% OUS market share.
Revenue GuidanceKRMD raised its revenue guidance reflecting growth of now 18-20%, underpinned by 8-10% SCIg market growth, global share gains, NRE revenue from 3 new expected collaborations, and its flow controller line extension.
Bears Say
Competitive PressuresThere is wariness of the potential for competitive pressures to expand going forward.
Valuation ConcernsKORU is valued at approximately twice the valuation shares traded at a year ago due to exceptional management of cash and significant progress with future growth opportunities.
REPRO-MED Systems News
KRMD FAQ
What was REPRO-MED Systems’s price range in the past 12 months?
REPRO-MED Systems lowest stock price was $1.86 and its highest was $5.05 in the past 12 months.
What is REPRO-MED Systems’s market cap?
REPRO-MED Systems’s market cap is $191.88M.
When is REPRO-MED Systems’s upcoming earnings report date?
REPRO-MED Systems’s upcoming earnings report date is Nov 05, 2025 which is in 83 days.
How were REPRO-MED Systems’s earnings last quarter?
REPRO-MED Systems released its earnings results on Aug 06, 2025. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.022 by $0.032.
Is REPRO-MED Systems overvalued?
According to Wall Street analysts REPRO-MED Systems’s price is currently Undervalued.
Does REPRO-MED Systems pay dividends?
REPRO-MED Systems does not currently pay dividends.
What is REPRO-MED Systems’s EPS estimate?
REPRO-MED Systems’s EPS estimate is -0.02.
How many shares outstanding does REPRO-MED Systems have?
REPRO-MED Systems has 46,234,960 shares outstanding.
What happened to REPRO-MED Systems’s price movement after its last earnings report?
REPRO-MED Systems reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.022. Following the earnings report the stock price went up 18.712%.
Which hedge fund is a major shareholder of REPRO-MED Systems?
Currently, no hedge funds are holding shares in KRMD
REPRO-MED Systems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.75 (14.46% Upside)
$4.75 (14.46% Upside)
Blogger Sentiment
Bullish
KRMD Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 6.8%
Last 30 Days ▼ 6.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
68.69%
12-Months-Change
Fundamentals
Return on Equity
-25.63%
Trailing 12-Months
Asset Growth
-6.55%
Trailing 12-Months
Company Description
REPRO-MED Systems
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
KRMD Company Deck
KRMD Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
KORU Medical Systems demonstrated significant revenue growth and international expansion, alongside advancements in product development and achieving positive cash flow. However, challenges such as a decline in gross margin and anticipated domestic inventory reductions present concerns.View all KRMD earnings summariesKRMD Stock 12 Month Forecast
Average Price Target
$4.75
▲(14.46% Upside)
Technical Analysis
InfuSystem Holdings
―
Retractable Technologies
―
Utah Medical Products
―
Milestone Scientific
―
Microbot Medical
―
Ownership Overview
17.32% Insiders
5.88% Mutual Funds
0.93% Other Institutional Investors
68.84% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---